A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...
This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...
Pfizer reported positive topline results in its phase three study of talazoparib in combination with enzalutamide to treat metastatic hormone-sensitive prostate cancer.
An Anglesey man wants to know why it took so long for Betsi health chiefs to start treatment on his "aggressive cancer" - a ...
As men age, their bodies go through many natural changes. One such change, often less spoken about, is the enlargement of the ...
Genes are only part of your story.
Learn how stress affects gut health, digestion, and bloating. Discover the gut-brain axis and simple ways to reduce stress and support your gut.
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...
A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form ...
ORNL is a leader both in developing advanced radiotherapies and in providing the radioisotopes needed for those therapies.
As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results